Scientific Concept of the National Cohort (status ... - Nationale Kohorte

291
References
67. Hecht, J.L. and G.L. Mutter, Molecular and pathologic aspects of endometrial
carcinogenesis. Journal of Clinical Oncology, 2006. 24(29): p. 4783.
68. Jass, J.R., Serrated adenoma of the colorectum and the DNA-methylator
phenotype. Nature Clinical Practice Oncology, 2005. 2(8): p. 398-405.
69. Jass, J.R., Classification of colorectal cancer based on correlation of clinical,
morphological and molecular features. Histopathology, 2007. 50(1): p. 113-130.
70. Rakha, E.A., et al., Expression profiling technology: its contribution to our
understanding of breast cancer. Histopathology, 2008. 52(1): p. 67-81.
71. Ricciardelli, C. and M.K. Oehler, Diverse molecular pathways in ovarian cancer
and their clinical significance. Maturitas, 2009. 62(3): p. 270-275.
72. Sato, M., et al., A translational view of the molecular pathogenesis of lung cancer.
Journal of Thoracic Oncology, 2007. 2(4): p. 327.
73. Scott, M. and W.G. McCluggage, Current concepts in ovarian epithelial
tumorigenesis: correlation between morphological and molecular data. Histology
and histopathology, 2006. 21(1): p. 81.
74. Snover, D.C., et al., Serrated polyps of the large intestine. American journal of
clinical pathology, 2005. 124(3): p. 380.
75. Toyota, M., et al., CpG island methylator phenotype in colorectal cancer.
Proceedings of the National Academy of Sciences of the United States of America,
1999. 96(15): p. 8681.
76. Yehiely, F., et al., Deconstructing the molecular portrait of basal-like breast
cancer. Trends in Molecular Medicine, 2006. 12(11): p. 537-544.
77. Felix, A.S., et al., Factors associated with Type I and Type II endometrial cancer.
Cancer Causes and Control, 2010: p. 1-6.
78. Anderson, W.F., et al., Comparison of age-specific incidence rate patterns for
different histopathologic types of breast carcinoma. Cancer Epidemiology
Biomarkers & Prevention, 2004. 13(7): p. 1128.
79. Colditz, G.A., et al., Risk factors for breast cancer according to estrogen and
progesterone receptor status. Journal of the National Cancer Institute, 2004. 96(3):
p. 218.
80. de Vogel, S., et al., Dietary folate and APC mutations in sporadic colorectal
cancer. Journal of Nutrition, 2006. 136(12): p. 3015.
81. Janssen-Heijnen, M.L.G. and J.W.W. Coebergh, The changing epidemiology of
lung cancer in Europe. Lung Cancer, 2003. 41(3): p. 245-258.
82. Weijenberg, M.P., et al., Dietary fat and risk of colon and rectal cancer with
aberrant MLH1 expression, APC or KRAS genes. Cancer Causes and Control,
2007. 18(8): p. 865-879.
83. Zhang, S.M., et al., Folate intake and risk of breast cancer characterized by
hormone receptor status. Cancer Epidemiology Biomarkers & Prevention, 2005.
14(8): p. 2004.
84. Kaaks, R. and P. Stattin, Obesity, Endogenous Hormone Metabolism, and
Prostate Cancer Risk: A Conundrum of “Highs” and “Lows”. Cancer Prevention
Research, 2010. 3(3): p. 259.
C.3